Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.

At times, aging doesn’t become evident in wrinkles or in gray hair, it occurs deep inside your body, in cells that have ...

Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

In today’s fast-paced and competitive biotechnology landscape, control and speed define success for companies and core labs ...

The enhanced ability to synthesise DNA, RNA and peptides has transformed biotechnology, enabling tremendous advances in ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) today announced that for the first time, an episode of a Netflix Original Series has been stored in Twist’s ...

Last year, during the Global Synthetic Biology (SynBioBeta) conference, Ansa Biotechnologies’ CEO Jason Gammack introduced attendees to the company’s first product—600 bp synthetic DNA constructs.

How do you define biosecurity in the context of DNA? Peccoud: An internet search for biosecurity will return stories about security measures aimed at preventing pests or infectious agents from ...

Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...